FOR PATIENTS · SOURCE READING
Treatment of children with tumors caused by MEN1 syndrome
Source: Childhood Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome, National Cancer Institute.
Source updated: Not stated in this source · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
NCI patient article for the named subtype within this topic Source-defined subtype article; do not apply its treatment text to every subtype in the umbrella topic.
Treatment of children with tumors caused by MEN1 syndrome
There are different types of treatment for children and adolescents with tumors caused by MEN1 syndrome. You and your child's cancer care team will work together to decide treatment. Many factors will be considered, such as your child's overall health and whether the cancer is newly diagnosed or has come back.
Your child's treatment plan will include information about the tumor, the goals of treatment, treatment options, and the possible side effects. It will be helpful to talk with your child's cancer care team before treatment begins about what to expect. For help every step of the way, see our booklet, Children with Cancer: A Guide for Parents.
Source links and citations
Surgery may be used to treat hyperparathyroidism, which is the most common sign of MEN1 syndrome. Children with MEN1 syndrome and primary hyperthyroidism may have surgery to remove at least three parathyroid glands and the thymus. Treatment is also given for pancreatic islet cell and pituitary tumors, and other conditions linked to MEN1 syndrome as needed.
Source links and citations
If the cancer comes back after treatment, your child's doctor will talk with you about what to expect and possible next steps. There might be treatment options that may shrink the cancer or control its growth. If there are no treatments, your child can receive care to control symptoms from cancer so they can be as comfortable as possible.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle